1OKeefe JH. Estrogen replacement after coronary angioplasty in woman[J]. J Am Coll Cardiol ,1997,29:15-20.
2Barrett-Connor E, Bush TL. Estrogen and coronary heart disease[J]. JAMA , 1991,265:1861-1867.
3Saitta A. Randomized, double-blind, placebo-controlled study on effects of raloxifene and hormone replacement therapy on plasma NO concentration, endothelin 1 levels, and endothelium-dependent vasodilation in postmenopausal women [ J ].Arterioscler Thromb Vasc Biol , 2001,21:1512-1519.
4Tanaka M. Effect of ovariectomy and estrogen replacement on aorta angiotensin converting enzyme activity in rats[J]. Jpn J Pharmacol , 1997,73:261-363.
5OSullivan MG, Goodrich JA, Adams MR. Increased prostacyclin synthesis by atherosclerotic arteries from estrogen-treated monkeys[J]. Life Sciences , 2001,69: 395-401.
7Nickenig G. Estrogen modulates AT1 receptor gene expression in vitro and in vivo[J]. Circulation , 1998,97: 2197-2201.
8Harris GM. Decreased plasma tissue factor pathway inhibitor in women taking combined oral contraceptive [ J]. Am J Hematol , 1999,60:175-180.
9Koh KK, Home MDK, Csako G, et al . Relation of fibrinolytic potentiation by estrogen to coagulation pathway activation in postmenopausal women[J]. Am J Cardiol , 1999,83: 466469.
10Kon Koh K. Relation of fibrinolytic potentiation by estrogen to coagulation pathway activation in postmenopausal women [J]. Am J Cardiol ,1999,83:466-469.
